EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) will present at two health care investor conferences in September, giving investors another opportunity to hear from the Exton-based injectable drug-delivery supplier as it operates a global manufacturing network generating more than $3 billion in annual sales.
West is scheduled to appear at the Wells Fargo Annual Healthcare Conference on Sept. 10 at 8:45 a.m. EDT in Everett, Massachusetts, followed by the Morgan Stanley Annual Global Healthcare Conference on Sept. 14 at 8:30 a.m. EDT in New York.
Live webcasts of both presentations will be available through the Investors section of West’s website. Replays are expected to remain available for approximately 90 days after each event.
The company did not identify which executives will participate in the conferences or specify topics they plan to discuss.
West supplies components, devices and other products used in the containment and delivery of injectable medicines. The company has more than 10,000 employees across 50 sites, including 26 manufacturing facilities, and supplies more than 41 billion components and devices annually.
Headquartered in Exton, West generated $3.07 billion in net sales in fiscal 2025. Its shares trade on the New York Stock Exchange under the ticker WST, and the company is a member of the S&P 500.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.